 Laura Borgelt
Concepts (171)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Contraceptive Agents | 3 | 2022 | 54 | 1.560 |
Why?
| | Medical Marijuana | 6 | 2020 | 97 | 1.540 |
Why?
| | Cannabis | 6 | 2021 | 383 | 1.370 |
Why?
| | Education, Pharmacy | 7 | 2022 | 121 | 1.310 |
Why?
| | Vitamins | 2 | 2021 | 150 | 1.210 |
Why?
| | Marijuana Use | 3 | 2018 | 167 | 1.100 |
Why?
| | Contraception, Postcoital | 2 | 2023 | 6 | 1.040 |
Why?
| | Dronabinol | 5 | 2022 | 118 | 1.020 |
Why?
| | Faculty, Pharmacy | 2 | 2022 | 16 | 0.950 |
Why?
| | Contraceptives, Oral, Hormonal | 2 | 2015 | 23 | 0.890 |
Why?
| | Abortion, Induced | 1 | 2023 | 71 | 0.810 |
Why?
| | Schools, Pharmacy | 2 | 2020 | 48 | 0.800 |
Why?
| | Levonorgestrel | 3 | 2023 | 31 | 0.800 |
Why?
| | Perimenopause | 1 | 2022 | 61 | 0.740 |
Why?
| | Pregnancy | 12 | 2023 | 5499 | 0.700 |
Why?
| | Nonprescription Drugs | 2 | 2018 | 68 | 0.700 |
Why?
| | Dietary Supplements | 2 | 2021 | 459 | 0.670 |
Why?
| | Epilepsy | 3 | 2020 | 278 | 0.640 |
Why?
| | Antirheumatic Agents | 1 | 2021 | 255 | 0.620 |
Why?
| | Endocannabinoids | 1 | 2018 | 36 | 0.610 |
Why?
| | Breast Feeding | 2 | 2018 | 366 | 0.610 |
Why?
| | Anticonvulsants | 2 | 2020 | 178 | 0.600 |
Why?
| | Prescription Drugs | 1 | 2018 | 116 | 0.530 |
Why?
| | Contraceptive Agents, Female | 2 | 2014 | 64 | 0.520 |
Why?
| | Teratogens | 1 | 2015 | 8 | 0.510 |
Why?
| | Pregnancy Outcome | 1 | 2018 | 337 | 0.510 |
Why?
| | Curriculum | 3 | 2020 | 813 | 0.490 |
Why?
| | Migraine Disorders | 1 | 2016 | 82 | 0.470 |
Why?
| | Pharmacists | 5 | 2021 | 231 | 0.460 |
Why?
| | Uterine Perforation | 1 | 2013 | 2 | 0.450 |
Why?
| | Intrauterine Device Migration | 1 | 2013 | 3 | 0.450 |
Why?
| | Intrauterine Devices, Medicated | 1 | 2013 | 23 | 0.430 |
Why?
| | Students, Pharmacy | 3 | 2021 | 97 | 0.410 |
Why?
| | Arthritis, Rheumatoid | 1 | 2021 | 1002 | 0.410 |
Why?
| | Phytotherapy | 1 | 2013 | 67 | 0.400 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2018 | 453 | 0.400 |
Why?
| | Contraception | 4 | 2022 | 117 | 0.400 |
Why?
| | Drug Labeling | 1 | 2012 | 42 | 0.400 |
Why?
| | Drug and Narcotic Control | 1 | 2012 | 29 | 0.400 |
Why?
| | Vomiting | 3 | 2017 | 122 | 0.400 |
Why?
| | Nandrolone | 1 | 2011 | 2 | 0.390 |
Why?
| | Contraceptives, Oral, Combined | 1 | 2011 | 17 | 0.390 |
Why?
| | Postpartum Period | 1 | 2013 | 275 | 0.370 |
Why?
| | Humans | 34 | 2023 | 114043 | 0.350 |
Why?
| | Hallucinogens | 2 | 2022 | 72 | 0.340 |
Why?
| | Female | 21 | 2023 | 59325 | 0.340 |
Why?
| | Minerals | 2 | 2021 | 37 | 0.330 |
Why?
| | Community Pharmacy Services | 2 | 2021 | 42 | 0.330 |
Why?
| | Estradiol | 1 | 2011 | 450 | 0.310 |
Why?
| | Cannabidiol | 2 | 2020 | 60 | 0.310 |
Why?
| | Cannabinoids | 3 | 2018 | 115 | 0.290 |
Why?
| | Educational Measurement | 3 | 2017 | 235 | 0.270 |
Why?
| | Menopause | 2 | 2022 | 271 | 0.250 |
Why?
| | Young Adult | 7 | 2021 | 10444 | 0.250 |
Why?
| | Adolescent | 7 | 2021 | 17800 | 0.250 |
Why?
| | Alabama | 1 | 2023 | 28 | 0.230 |
Why?
| | Contraceptives, Oral | 1 | 2023 | 25 | 0.220 |
Why?
| | Marijuana Abuse | 4 | 2018 | 211 | 0.210 |
Why?
| | Adult | 10 | 2021 | 30375 | 0.200 |
Why?
| | Diet | 2 | 2021 | 1080 | 0.200 |
Why?
| | Faculty | 1 | 2022 | 126 | 0.180 |
Why?
| | Prescriptions | 1 | 2021 | 60 | 0.180 |
Why?
| | Retrospective Studies | 6 | 2021 | 12521 | 0.180 |
Why?
| | Methotrexate | 1 | 2021 | 227 | 0.170 |
Why?
| | Length of Stay | 2 | 2021 | 957 | 0.170 |
Why?
| | Progesterone | 1 | 2021 | 232 | 0.170 |
Why?
| | Professional Competence | 1 | 2019 | 81 | 0.160 |
Why?
| | Lennox Gastaut Syndrome | 1 | 2019 | 16 | 0.160 |
Why?
| | Plant Extracts | 1 | 2020 | 154 | 0.160 |
Why?
| | Directive Counseling | 1 | 2018 | 41 | 0.150 |
Why?
| | Health Care Costs | 1 | 2021 | 381 | 0.150 |
Why?
| | Stillbirth | 1 | 2018 | 57 | 0.150 |
Why?
| | Colorado | 5 | 2018 | 4090 | 0.150 |
Why?
| | Congenital Abnormalities | 1 | 2018 | 72 | 0.150 |
Why?
| | Off-Label Use | 1 | 2018 | 51 | 0.150 |
Why?
| | Infant, Low Birth Weight | 1 | 2018 | 124 | 0.150 |
Why?
| | Infant, Newborn | 2 | 2018 | 5038 | 0.150 |
Why?
| | Fertilization | 1 | 2018 | 41 | 0.150 |
Why?
| | Commerce | 1 | 2018 | 61 | 0.150 |
Why?
| | Micronutrients | 1 | 2018 | 77 | 0.140 |
Why?
| | Drug Therapy | 1 | 2017 | 74 | 0.140 |
Why?
| | Problem-Based Learning | 2 | 2017 | 77 | 0.140 |
Why?
| | Education, Pharmacy, Graduate | 1 | 2017 | 18 | 0.140 |
Why?
| | Risk Factors | 2 | 2022 | 8614 | 0.140 |
Why?
| | Professional-Patient Relations | 1 | 2018 | 140 | 0.140 |
Why?
| | Pharmacies | 1 | 2017 | 32 | 0.140 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2018 | 176 | 0.130 |
Why?
| | Leadership | 1 | 2019 | 291 | 0.130 |
Why?
| | Fetal Development | 1 | 2018 | 248 | 0.130 |
Why?
| | United States Food and Drug Administration | 2 | 2017 | 172 | 0.130 |
Why?
| | Prenatal Care | 1 | 2018 | 250 | 0.130 |
Why?
| | Premature Birth | 1 | 2018 | 275 | 0.120 |
Why?
| | Women | 1 | 2015 | 51 | 0.120 |
Why?
| | Faculty, Medical | 1 | 2017 | 226 | 0.120 |
Why?
| | Administration, Oral | 2 | 2019 | 725 | 0.120 |
Why?
| | Drug Interactions | 1 | 2015 | 337 | 0.110 |
Why?
| | Parents | 1 | 2021 | 1181 | 0.110 |
Why?
| | Self Report | 1 | 2017 | 695 | 0.110 |
Why?
| | United States | 4 | 2020 | 12137 | 0.110 |
Why?
| | Pharmaceutical Services | 1 | 2014 | 76 | 0.110 |
Why?
| | Spasm | 1 | 2013 | 19 | 0.110 |
Why?
| | Animals | 5 | 2022 | 31565 | 0.100 |
Why?
| | Receptor, Cannabinoid, CB1 | 1 | 2013 | 28 | 0.100 |
Why?
| | Estrogen Replacement Therapy | 1 | 2014 | 116 | 0.100 |
Why?
| | Counseling | 1 | 2015 | 342 | 0.100 |
Why?
| | Program Evaluation | 1 | 2017 | 820 | 0.100 |
Why?
| | Teaching | 1 | 2014 | 209 | 0.100 |
Why?
| | Prevalence | 1 | 2018 | 2247 | 0.100 |
Why?
| | Drug Approval | 1 | 2012 | 78 | 0.100 |
Why?
| | Macaca mulatta | 2 | 2022 | 131 | 0.100 |
Why?
| | Child | 5 | 2021 | 18400 | 0.100 |
Why?
| | Surveys and Questionnaires | 2 | 2020 | 4595 | 0.090 |
Why?
| | Radiography | 1 | 2013 | 803 | 0.090 |
Why?
| | Interpersonal Relations | 1 | 2014 | 338 | 0.090 |
Why?
| | Cross-Sectional Studies | 2 | 2018 | 4402 | 0.090 |
Why?
| | Risk | 1 | 2013 | 810 | 0.090 |
Why?
| | Drug Costs | 1 | 2011 | 92 | 0.090 |
Why?
| | Drug Combinations | 1 | 2011 | 286 | 0.090 |
Why?
| | Drug Administration Schedule | 1 | 2011 | 714 | 0.080 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2012 | 239 | 0.080 |
Why?
| | Treatment Outcome | 2 | 2013 | 9049 | 0.080 |
Why?
| | Clinical Trials as Topic | 1 | 2013 | 926 | 0.080 |
Why?
| | Health Services Accessibility | 3 | 2020 | 756 | 0.070 |
Why?
| | Nausea | 2 | 2018 | 99 | 0.070 |
Why?
| | Pain | 1 | 2013 | 701 | 0.070 |
Why?
| | Aged, 80 and over | 1 | 2016 | 6306 | 0.060 |
Why?
| | Cannabinoid Receptor Agonists | 1 | 2022 | 30 | 0.050 |
Why?
| | Male | 5 | 2020 | 55396 | 0.050 |
Why?
| | Middle Aged | 3 | 2017 | 26605 | 0.050 |
Why?
| | Periodicity | 1 | 2021 | 54 | 0.050 |
Why?
| | Anti-Mullerian Hormone | 1 | 2021 | 50 | 0.050 |
Why?
| | Prolactin | 1 | 2021 | 96 | 0.050 |
Why?
| | Thyrotropin | 1 | 2021 | 100 | 0.050 |
Why?
| | Reproductive Health | 1 | 2021 | 70 | 0.040 |
Why?
| | Menstrual Cycle | 1 | 2021 | 108 | 0.040 |
Why?
| | Luteinizing Hormone | 1 | 2021 | 169 | 0.040 |
Why?
| | Trust | 1 | 2021 | 103 | 0.040 |
Why?
| | Follicle Stimulating Hormone | 1 | 2021 | 216 | 0.040 |
Why?
| | Staff Development | 1 | 2019 | 39 | 0.040 |
Why?
| | Metabolic Clearance Rate | 1 | 2019 | 102 | 0.040 |
Why?
| | Half-Life | 1 | 2019 | 141 | 0.040 |
Why?
| | Biological Availability | 1 | 2019 | 119 | 0.040 |
Why?
| | Delphi Technique | 1 | 2019 | 157 | 0.040 |
Why?
| | Tissue Distribution | 1 | 2019 | 285 | 0.040 |
Why?
| | Fetus | 1 | 2022 | 698 | 0.040 |
Why?
| | Morning Sickness | 1 | 2018 | 4 | 0.040 |
Why?
| | Aged | 1 | 2016 | 18969 | 0.040 |
Why?
| | Pregnancy Trimester, First | 1 | 2018 | 125 | 0.040 |
Why?
| | Legislation, Drug | 1 | 2018 | 78 | 0.040 |
Why?
| | Placenta | 1 | 2022 | 628 | 0.030 |
Why?
| | Professional Role | 1 | 2018 | 148 | 0.030 |
Why?
| | Syndrome | 1 | 2016 | 330 | 0.030 |
Why?
| | Education, Medical, Undergraduate | 1 | 2017 | 160 | 0.030 |
Why?
| | Child, Preschool | 2 | 2019 | 9114 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 1836 | 0.030 |
Why?
| | Quality Improvement | 1 | 2021 | 944 | 0.030 |
Why?
| | Rural Population | 1 | 2017 | 443 | 0.030 |
Why?
| | Marijuana Smoking | 1 | 2017 | 224 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2014 | 158 | 0.030 |
Why?
| | Family Planning Services | 1 | 2014 | 68 | 0.030 |
Why?
| | Drug Compounding | 1 | 2014 | 89 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2016 | 1331 | 0.030 |
Why?
| | Comprehension | 1 | 2014 | 151 | 0.030 |
Why?
| | Educational Status | 1 | 2014 | 408 | 0.020 |
Why?
| | Women's Health | 1 | 2014 | 270 | 0.020 |
Why?
| | Attitude of Health Personnel | 1 | 2018 | 970 | 0.020 |
Why?
| | Patient Education as Topic | 1 | 2014 | 666 | 0.020 |
Why?
| | Communication | 1 | 2014 | 734 | 0.020 |
Why?
| | Prospective Studies | 1 | 2019 | 6195 | 0.020 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2014 | 1168 | 0.020 |
Why?
| | Infant | 1 | 2018 | 7943 | 0.020 |
Why?
|
|
Borgelt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|